萬潤股份(002643.SZ)擬捐贈500萬元支持抗擊新型冠狀病毒肺炎疫情
格隆匯2月24日丨萬潤股份(002643.SZ)公佈,自新型冠狀病毒肺炎疫情暴發以來,公司堅決貫徹落實黨中央、國務院決策部署,積極投身疫情防控工作,切實保護員工身體健康與生命安全,維護公司正常生產經營秩序。為積極履行企業社會責任,共同抗擊疫情,公司及公司子公司計劃合計向武漢市紅十字會捐助防疫專項資金500萬元用於支持疫情防控工作。其中,公司捐助資金300萬元,公司控股子公司煙台九目化學股份有限公司計劃捐助資金100萬元,公司全資子公司煙台萬潤藥業有限公司計劃捐助資金50萬元,公司全資子公司煙台海川化學制品有限公司計劃捐助資金50萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.